That is necessary, due to the fact that the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we need to understand how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error procedure (diplomatic relations). Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. This was a breakthrough practically nobody noticed. But it's going to have profound implications for curing disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be lots of investment opportunities in this space, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (angel investor). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back perhaps considerably before going higher - self-driving cars. I have actually been covering bitcoin for a long period of time now. One of the first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mainly educating readers. However that's not the huge concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. exponential growth. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are so lots of great private business on the brink of striking the public markets And I have actually been working on a new way for you to invest even prior to these business go public.
This opportunity has been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the details. Go right here to schedule your spot for totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers know that tech isn't our usual beat (artificial intelligence). And when it comes to tech investing, we leave it to the experts. Luckily, we have several such experts in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (social media). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These patterns are experiencing exponential development and developing incredible opportunities for investors. I wish to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. diplomatic relations. However in spite of what lots of readers might believe, this is a trend that's simply starting. Although the COVID-19 pandemic interfered with supply chains last year, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually caused Apple delaying the release of the 5G-enabled i, Phone 12 by two months (the legacy report prediction). Losing two months of manufacturing and sales really impacts how lots of 5G gadgets are offered in the fiscal year. When you think about all of that, offering 250 million units is exceptional. More significantly, the delays brought on by the pandemic developed a lots of bottled-up need. And that need is now going to be pressed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown biotech pick. Which's not my only 5G forecast When I have actually talked about 5G in the past, I've explained its 3 different stages.
In Phase Two, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Stage Three, 5G services begin to be provided (last week). That's when we start to see applications working on 5G networks. Think of things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase Three by this summertime. This starts something of a virtuous cycle: The majority of people do not really appreciate the innovation. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That results in more 5G apps being developed. In reality, 5G is going to open a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities moving forward will be huge. Stepping far from 5G, the next essential technology I predict in 2021 is CRISPR hereditary modifying. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For several years, CRISPR was primarily a specific niche technology that wasn't well understood. And during that time, there were actually only 3 companies running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're treating illness and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing unbelievable returns. This entire industry is successfully a greenfield opportunity.
There's room for many companies to exist in this area. jeff brown 2020 predictions. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the convergence of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can precisely anticipate the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is essential since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been an experimental process. And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to create drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but numerous drug treatments produced utilizing this technology. This was one of those advancements that practically nobody saw. However it's going to have profound implications for curing disease. And, obviously, there will be lots of financial investment opportunities in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it drew back maybe considerably prior to going greater. I've been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin - jeff brown genome sequencing stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that preliminary recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. jeff bezos. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date since February 2021, however we might not separately validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to choose winning technology stocks. He spent more than 25 years investigating technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an exceptional point of view on the market. He's constantly on the hunt for new chances, and he shares much of his best choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he successfully predicted some of the biggest economic events of the past twenty years. Although he does not appear to release his picks to the public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it best whenever, however Jeff Brown's accurate forecasts have earned him legions of devoted followers. That states a lot about his ability. The Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research study uses several research services with a wide array of specializations - jeff brown biotech stock pick for 2020.
The company is also associated with Bonner & Partners, another well-respected research study publisher - melania trump. On its website, Brownstone says its objective is to provide retail investors with professional-grade research: "For too long, the finest investment research study has actually not been offered to specific financiers. It has actually been typically scheduled for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown genome sequencing. The mission of Brownstone Research study is to make that kind of proprietary research readily available to any investors seeking to acquire an edge in the markets. The goal is easy to deliver unique and profitable investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its customers. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout many of America. If you understand even a bit about the market, you understand that he has a reputation as a King Midas of sorts. future report review. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown thinks S.A.V. artificial intelligence. could be "the most significant pattern of the 2020s, and he's not alone. Check out these quotes from other popular S.A.V. bulls: Elon's next big act will be weding two cutting-edge technologies: expert system and electric cars and trucks. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars ever. It's absolutely nothing except the vehicle market's Holy Grail. As you understand, electrical lorries and self-driving vehicle stocks have been big this year, but the Wall Street maker has been big on hype without much tangible result. In spite of an extreme boost in competition over the previous few years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech might be the magic string that connects all of it together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transportation. Essentially, this innovation would permit you to rent your car as a self-governing, self-driving taxi when you're not utilizing it. You simply leave the cars and truck and press a button on an app that informs the vehicle to "join the fleet." Next thing you know, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the revenues. It sounds crazy, but it might be closed than you think.